Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials

1

Transurethral resection of the prostate (TURP) is the gold standard for benign prostatic hyperplasia despite the emergence of minimally invasive techniques.
2

Technological advancements in TURP over the last two decades have improved surgical techniques and endoscopic equipment, potentially reducing complications.
3

A systematic review included 103 randomized clinical trials, analyzing TURP outcomes from 2000 to 2022, focusing on efficacy and safety.
4

The average decrease in International Prostate Symptom Score (IPSS) at > 3 years improved over time, indicating better outcomes in recent studies.
5

Improvements in maximum urine flow rate (Qmax) were significant, particularly in studies from 2010-2014, highlighting advancements in TURP efficacy.

World Journal Of Urology

by Joao G. Porto, Ansh M. Bhatia, Abhishek Bhat, Maria Camila Suarez Arbelaez, Ruben Blachman-Braun, Khushi Shah, Ankur Malpani, Diana Lopategui, Thomas R. W. Herrmann, Robert Marcovich, Hemendra N. Shah
November 15, 2024

1